PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 1, 1994Archives of General Psychiatry460 citations

Sympathetic Nervous System Activity in Major Depression

View Full Paper
RVRichard C. Veith

Key Points

  • This research aims to investigate whether increased plasma norepinephrine levels in major depression indicate higher sympathetic nervous system activity and how desipramine affects this activity.
  • Assessed sympathetic nervous system activity using isotope-dilution plasma norepinephrine kinetic technique in depressed patients and controls.

Structured PICO

Does desipramine alter sympathetic nervous system activity in patients with major depression?

P
Population
17 patients with major depression and 36 controls
I
Intervention
Desipramine hydrochloride (short-term for 2 days, long-term for 28 days)
C
Comparator
Healthy controls (for baseline comparison) and baseline values (for treatment effect)
O
Outcome
Sympathetic nervous system activity assessed by plasma norepinephrine (NE) kinetics (rate of NE appearance into extravascular and vascular compartments, and rate of NE clearance)surrogate

Sympathetic nervous system activity is elevated in major depression and is initially suppressed but later reactivated by prolonged desipramine treatment.

Abstract

BACKGROUND: To determine whether elevations of plasma norepinephrine (NE) in major depression represent increased sympathetic nervous system (SNS) activity and to assess the effects of desipramine hydrochloride on sympathetic function. METHODS: SNS activity was assessed in depressed patients and controls by an isotope-dilution, plasma NE kinetic technique using mathematical modeling and compartmental analysis. This approach provided estimates of the rate of NE appearance into an extravascular compartment, which is the site of endogenous NE release from SNS nerves, the corresponding rate of NE appearance into plasma, and the rate of NE clearance from plasma. RESULTS: Norepinephrine appearance into the extravascular and vascular compartments was significantly elevated in 17 depressed patients compared with that in 36 controls. The rate of NE clearance from plasma was similar in both groups. This is compatible with increased SNS activity in major depression. Desipramine, given for 2 days, significantly reduced the concentration of NE in plasma of patients and controls by markedly suppressing the rates of extravascular and vascular NE appearance, compatible with a short-term reduction in SNS activity. Desipramine prolonged the rate of NE clearance from plasma, consistent with a blockade of NE re-uptake into SNS nerve terminals. The initial suppression of SNS activity by desipramine was reversed by long-term (28 days) treatment of patients, with extravascular and vascular NE appearance rates returning to approximately basal levels. An associated rise in plasma NE concentrations compared with the baseline was attributable to a progressive reduction in plasma NE clearance. CONCLUSION: Sympathetic nervous system activity is elevated in major depression and is suppressed by short-term desipramine administration. The demonstration of SNS reactivation occurring with prolonged desipramine treatment is compatible with the theory that long-term treatment desensitizes CNS alpha 2-adrenergic receptors and emphasizes the value of examining the temporal course of responses to pharmacological challenges of neuroendocrine systems. Previously reported elevations of plasma NE during prolonged administration of tricyclic antidepressants are probably the result of a reduction in plasma NE clearance, not an increase in SNS activity.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Richard C. Veith (1994) studied this question.

synapsesocial.com/papers/6a10ef63497e609eda647a28https://doi.org/10.1001/archpsyc.1994.03950050071008
Ask AI
Helpful
Bookmark
Share
View Full Paper